CSPG4过度表达意味着在声的手术干预后,复发和瘤发生的风险更高
相关实验视频
Updated: May 30, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
369
Jiajia Shi1, Lei Cheng1, Min Chen1
1ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, 83 FenYang Road, Shanghai, 200031, China.
概括
在声白血病 (VFL) 中,氏硫酸蛋白质糖4 (CSPG4) 的过度表达预测了更高的风险和更短的复发时间. CSPG4可以作为评估VFL患者结果的新生物标志物.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
背景情况:
- 声白血病 (VFL) 是一种癌前喉病变,缺乏可靠的预后生物标志物.
- 丁硫酸盐蛋白甘4 (CSPG4) 涉及恶性瘤,包括喉状细胞癌.
研究的目的:
- 调查VFL患者中CSPG4表达的预后价值.
- 确定CSPG4是否可以预测VFL的复发和恶性转变.
主要方法:
- 一项对44名接受外科手术的VFL患者的队列研究.
- 免疫组织化学被用来评估CSPG4表达.
- 使用斯皮尔曼相关性和考克斯回归分析来评估预后关系.
主要成果:
- 更高的CSPG4表达 (H-SCORE) 与复发率和恶性转变率的增加显著相关.
- CSPG4 H-SCORE显示出对预后不佳的预测价值 (AUC为0.742和0.710).
- CSPG4 H-SCORE,病变大小和病理类型是复发和恶性转变的重要预测因素.
结论:
- 在VFL中CSPG4的过度表达与更高的风险和更短的复发和瘤产生时间框架有关.
- CSPG4检测为评估VFL患者预后提供了潜在的新方法.
相关概念视频
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K

